Navigation Links
Vapotherm CEO Receives Top Business Leadership Award From World Trade Center Institute
Date:3/3/2008

STEVENSVILLE, Md., March 3 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Oxygen Therapy products, announced today that its President & CEO, Robert Storey earned Maryland's 2008 International Business Leadership Award from the World Trade Center Institute (WTCI). Storey was one of seven winners selected by the WTCI for exceptional business leadership, determination, and creative strategy in international business. The award will be presented to Storey at a ceremony on March 12 at the American Visionary Arts Museum in Baltimore.

"It is particularly gratifying to have one's work recognized publicly by peers who understand how challenging it is to operate effectively in a global environment," said Storey. "However, this award is the result of a Corporate-wide effort by a management team that is second to none in our industry. That is the true story behind this honor."

Established in 1989, WTCI is the region's premier private sector international business partner. WTCI, financed jointly by area businesses and the State of Maryland, operates as a non-profit membership organization.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit http://www.vtherm.com.

CONTACT:

Amy Elias/Jamie Watt

Profiles, Inc.

410-243-3790

amy@profilespr.com

jamie@profilespr.com


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Vapotherm Earns Achievement Award from U.S. Department Of Commerce
2. Fujifilm Receives FDA Approval for Unity SpeedSuite(TM)
3. Bart De Strooper receives prestigious $200,000 Alzheimer Prize
4. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
5. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
6. Boca Pharmacal Receives FDA Approval for Carbinoxamine Oral Solution
7. IDC receives patent on dual energy imaging technology
8. Kryptiq Customer Receives HIMSS Nicholas E. Davies Award of Excellence
9. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
10. Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies
11. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
Breaking Medicine Technology: